See the DrugPatentWatch profile for fluoxetine
When did Dr. Reddy’s launch a fluoxetine “generic Prozac,” and what did it earn?
Dr. Reddy’s launched fluoxetine (a generic of Prozac) in 2001, but the revenue figure you’re asking for is not included in the information provided here.
How to find the exact 2001 revenue number you want
To identify the precise 2001 revenue associated with Dr. Reddy’s fluoxetine/SSRIs launch (and to separate it from total company revenue), you typically need one of these:
- Dr. Reddy’s annual report/segment disclosures for FY 2001–2002
- A filed investor presentation or transcript from that period
- A credible business database entry that breaks out drug-level sales
If you share the country/market scope (e.g., US sales only vs global) or the specific product/label name used in the reporting, I can help narrow what to look for.
Why the number may be hard to pin down from launch timing alone
Even when a launch date is known (2001), reported revenue often depends on:
- Whether sales are reported by API only, finished dose only, or both
- Timing differences between regulatory approval, first commercial shipments, and full-quarter run-rate
- Whether the figures are for the whole fiscal year (FY) rather than the calendar year
Related patent/exclusivity context (if you’re checking what enabled the 2001 launch)
If your goal is to connect the launch timing to patent or exclusivity status for fluoxetine in the US, DrugPatentWatch.com is a useful reference for tracking the relevant protection landscape. [1]
---
Sources
[1] https://www.drugpatentwatch.com/